Global Atrial Fibrillation Devices Market to Reach $15.9 Billion by 2030
The global market for Atrial Fibrillation Devices estimated at US$6.3 Billion in the year 2022, is projected to reach a revised size of US$15.9 Billion by 2030, growing at a CAGR of 12.3% over the analysis period 2022-2030. EP Ablation Catheters, one of the segments analyzed in the report, is projected to record a 14.8% CAGR and reach US$4.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the EP Diagnostic Catheters segment is readjusted to a revised 11.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 17.2% CAGR
The Atrial Fibrillation Devices market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 17.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.8% and 10.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.4 Billion by the year 2030.Select Competitors (Total 34 Featured) -
- Abbott Laboratories, Inc.
- AtriCure, Inc.
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- CardioFocus, Inc.
- Johnson & Johnson
- Koninklijke Philips NV
- Medtronic PLC
- MicroPort Scientific Corporation
- OSYPKA AG
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories, Inc.
- AtriCure, Inc.
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- CardioFocus, Inc.
- Johnson & Johnson
- Koninklijke Philips NV
- Medtronic PLC
- MicroPort Scientific Corporation
- OSYPKA AG
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 93 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 6.3 Billion |
Forecasted Market Value ( USD | $ 15.9 Billion |
Compound Annual Growth Rate | 12.3% |
Regions Covered | Global |